Asian Phytoceuticals PCL
SET:APCO
Operating Income
Forecast
Operating Income Estimate
Asian Phytoceuticals PCL
For the last 13 years the compound annual growth rate for Asian Phytoceuticals PCL's operating income is -2%. The projected CAGR for the next 11 years is 7%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APCO's stock price target?
Not Available
APCO doesn't have any price targets made by Wall Street professionals.
What is Asian Phytoceuticals PCL's Revenue forecast?
Projected CAGR
5%
For the last 13 years the compound annual growth rate for Asian Phytoceuticals PCL's revenue is -2%. The projected CAGR for the next 11 years is 5%.
What is Asian Phytoceuticals PCL's Operating Income forecast?
Projected CAGR
7%
For the last 13 years the compound annual growth rate for Asian Phytoceuticals PCL's operating income is -2%. The projected CAGR for the next 11 years is 7%.
What is Asian Phytoceuticals PCL's Net Income forecast?
Projected CAGR
6%
For the last 13 years the compound annual growth rate for Asian Phytoceuticals PCL's net income is 1%. The projected CAGR for the next 11 years is 6%.
You don't have any saved screeners yet
